Hemp Gazette wrote an article covering Ananda Hemp’s clinical trail.
“… the race is on to be the first to market to tap into the pent-up demand in Australia for OTC CBD.
Targeting restless sleepers, Southern Cross University researchers have commenced a Phase IIb double blind, randomised, placebo-controlled, multi-site clinical trial funded Australia’s Ecofibre. Ecofibre subsidiary Ananda Hemp’s CBD extract in the form of a low-dose botanical CBD soft gel will be used in the trial and compared to a placebo.”
Read more on their website: